Check-Cap (CHEK) Stock Price, News & Analysis

Company Overview

Check-Cap Ltd. (NASDAQ: CHEK) is a medical technology company focused on transforming colorectal cancer screening through its novel C-Scan system. Headquartered in Israel with offices in the United States, Check-Cap develops and commercializes an ingestible, low-dose X-ray capsule designed to generate high-resolution, three-dimensional images of the colon. The company’s mission is to offer a more patient-friendly alternative to conventional colonoscopy, reducing discomfort and preparation requirements while maintaining diagnostic accuracy.

The core offering of Check-Cap is the C-Scan platform, which combines a swallowable capsule with an external detector and proprietary software. Once ingested, the capsule travels naturally through the gastrointestinal tract, emitting ultra-low-dose X-rays that are captured by a sensor belt worn by the patient. The data are then reconstructed into detailed colon images for physician review. By eliminating sedation and minimizing the need for extensive bowel preparation, this technology aims to increase screening compliance among individuals at average risk of colorectal cancer.

Founded in 2004, Check-Cap has completed multiple clinical studies in Israel and the United States to evaluate the safety and efficacy of its C-Scan system. The company is advancing its regulatory filings with health authorities, including the U.S. Food and Drug Administration, and is preparing for potential commercialization in key markets. Led by CEO Douglas D. Eberhardt and supported by a management team with deep experience in medical devices and imaging technology, Check-Cap continues to engage in strategic collaborations and research partnerships to expand its product pipeline and geographic reach.

Key Stats

• Today's Range: $0.77 to $0.79
• 50-Day Range: $0.73 to $1.03
• 52-Week Range: $0.56 to $3.04
• Volume: 7,088 shs
• Average Volume: 378,735 shs
• Market Capitalization: $4.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Check-Cap Stock Analysis - MarketRank™

Check-Cap scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Check-Cap.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Check-Cap is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Check-Cap is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Check-Cap has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.45% of the float of Check-Cap has been sold short.

Short Interest Ratio / Days to Cover

Check-Cap has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Check-Cap has recently decreased by 18.85%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Check-Cap does not currently pay a dividend.

Dividend Growth

Check-Cap does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.45% of the float of Check-Cap has been sold short.

Short Interest Ratio / Days to Cover

Check-Cap has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Check-Cap has recently decreased by 18.85%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Check-Cap this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Check-Cap insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.48% of the stock of Check-Cap is held by insiders.

Percentage Held by Institutions

Only 1.07% of the stock of Check-Cap is held by institutions.

CHEK Stock Analysis - Frequently Asked Questions

How have CHEK shares performed this year?

Check-Cap's stock was trading at $0.9899 at the beginning of the year. Since then, CHEK stock has decreased by 20.7% and is now trading at $0.7850.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.39.

When did Check-Cap's stock split?

Shares of Check-Cap reverse split on Friday, November 25th 2022.The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Check-Cap IPO?

Check-Cap (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Check-Cap own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Check-Cap investors own include NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA).

Company Calendar

• Last Earnings: 11/27/2023
• Today: 7/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:CHEK
• CIK: 1610590
• Web: www.check-cap.com
• Phone: 972546706451
• Fax: 972-4821-1267
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.05 per share
• Price / Book: 0.20

Miscellaneous

• Outstanding Shares: 5,850,000
• Free Float: 5,823,000
• Market Cap: $4.68 million
• Optionable: Not Optionable
• Beta: 0.19